UB
KRYS icon

UMB Bank’s Krystal Biotech KRYS Stock Holding History

UMB Bank’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.9K Buy
172
+21
+14% +$6.27K ﹤0.01% 1220
2026
Q1 		$39K Buy
151
+7
+5% +$1.86K ﹤0.01% 1347
2025
Q4 		$35.5K Buy
144
+37
+35% +$7.79K ﹤0.01% 1363
2025
Q3 		$18.9K Buy
107
+64
+149% +$9.58K ﹤0.01% 1462
2025
Q2 		$5.91K Sell
43
-30
-41% -$4.41K ﹤0.01% 1781
2025
Q1 		$13.2K Buy
73
+38
+109% +$6.39K ﹤0.01% 1456
2024
Q4 		$5.48K Sell
35
-23
-40% -$4.08K ﹤0.01% 1680
2024
Q3 		$10.6K Buy
58
+32
+123% +$6.17K ﹤0.01% 1465
2024
Q2 		$4.78K Buy
+26
New +$4.37K ﹤0.01% 1449

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

UMB Bank's KRYS Position: Q2 2026 in Review

UMB Bank increased its Krystal Biotech (KRYS) stake by 14% in Q2 2026, buying an estimated $6.27K and bringing the position to 172 shares worth $63.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1220.

UMB Bank first reported a position in KRYS in Q2 2024 and has held it in 9 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • UMB Bank held 172 shares of Krystal Biotech worth $63.9K as of Q2 2026.
  • UMB Bank bought 21 Krystal Biotech shares in Q2 2026, an estimated $6.27K.
  • Krystal Biotech made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1220 holding.
  • UMB Bank first reported a position in Krystal Biotech in Q2 2024 and has held it in 9 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.